Health
Experts meeting after man developed rare blood clotting condition after AstraZeneca vaccine – 7NEWS.com.au
A man, in his 40s, is in a Melbourne hospital after receiving the AstraZeneca vaccine on March 22.
The Australian governments top medical advisory body is set to receive further expert guidance on the AstraZeneca COVID-19 vaccine following investigations into whether its linked to a Melbourne mans rare blood clot condition.
The Therapeutic Goods Administration and the Australian Technical Advisory Group on Immunisation on Saturday will update the AHPPC on the condition, which the man has suffered for the first time.
The man, in his 40s, is in a Melbourne hospital after receiving the AstraZeneca…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?